Retatrutide Description
Retatrutide is a multi‑receptor incretin agonist (GLP‑1, GIP, glucagon) designed to amplify appetite suppression, glycemic control, and metabolic outcomes—showing strong weight‑loss efficacy in clinical phases.
Benefits of Retatrutide
- Robust weight‑loss efficacy observed in trials
- Appetite suppression and metabolic support
- May outperform single‑pathway incretins in studies
